| skeletal system development | GO:0001501 | 356 | 0.885 | Mouse |
| extracellular matrix organization | GO:0030198 | 147 | 0.862 | |
| chondrocyte development | GO:0002063 | 24 | 0.861 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.832 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.832 | |
| extracellular structure organization | GO:0043062 | 148 | 0.819 | |
| respiratory tube development | GO:0030323 | 167 | 0.797 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.762 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.721 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.715 | |
| cartilage development | GO:0051216 | 140 | 0.680 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.650 | |
| forebrain development | GO:0030900 | 302 | 0.636 | |
| angiogenesis | GO:0001525 | 201 | 0.611 | |
| cerebral cortex development | GO:0021987 | 86 | 0.609 | |
| response to acid chemical | GO:0001101 | 111 | 0.589 | |
| ossification | GO:0001503 | 216 | 0.520 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.516 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.513 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.512 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.512 | |
| connective tissue development | GO:0061448 | 179 | 0.469 | |
| cardiac chamber development | GO:0003205 | 108 | 0.453 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.446 | |
| wound healing | GO:0042060 | 157 | 0.434 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.433 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.432 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.428 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.422 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.387 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.375 | |
| lung development | GO:0030324 | 164 | 0.367 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.350 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.344 | |
| notochord development | GO:0030903 | 20 | 0.327 | Zebrafish |
| response to growth factor | GO:0070848 | 198 | 0.323 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.320 | |
| tissue homeostasis | GO:0001894 | 115 | 0.319 | |
| pallium development | GO:0021543 | 120 | 0.307 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.303 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.302 | |
| negative regulation of gastrulation | GO:2000542 | 3 | 0.298 | |
| cell adhesion | GO:0007155 | 329 | 0.291 | |
| digestive tract development | GO:0048565 | 190 | 0.285 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.282 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.279 | |
| gland development | GO:0048732 | 330 | 0.276 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.269 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.268 | |
| forebrain cell migration | GO:0021885 | 58 | 0.266 | |
| regulation of toll signaling pathway | GO:0008592 | 1 | 0.258 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.253 | |
| telencephalon development | GO:0021537 | 186 | 0.248 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.245 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.243 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.242 | |
| retinal blood vessel morphogenesis | GO:0061304 | 3 | 0.229 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.226 | |
| neuron migration | GO:0001764 | 122 | 0.225 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.219 | |
| appendage development | GO:0048736 | 166 | 0.215 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.209 | |
| proteoglycan metabolic process | GO:0006029 | 38 | 0.208 | |
| muscle tissue development | GO:0060537 | 308 | 0.208 | |
| cartilage condensation | GO:0001502 | 18 | 0.205 | |
| limb development | GO:0060173 | 166 | 0.198 | |
| sprouting angiogenesis | GO:0002040 | 26 | 0.197 | |
| multicellular organismal macromolecule metabolic process | GO:0044259 | 19 | 0.191 | |
| response to amino acid | GO:0043200 | 37 | 0.190 | |
| sensory perception | GO:0007600 | 245 | 0.183 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.182 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.182 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.180 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.179 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.176 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.175 | |
| limb morphogenesis | GO:0035108 | 149 | 0.175 | |
| endoderm development | GO:0007492 | 45 | 0.173 | |
| bone development | GO:0060348 | 120 | 0.172 | |
| protein processing | GO:0016485 | 163 | 0.172 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.169 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.165 | |
| ear development | GO:0043583 | 200 | 0.161 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.156 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.156 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.155 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.152 | |
| gliogenesis | GO:0042063 | 141 | 0.151 | |
| kidney development | GO:0001822 | 213 | 0.151 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.148 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.144 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.144 | |
| response to inorganic substance | GO:0010035 | 96 | 0.140 | |
| regulation of cell migration | GO:0030334 | 219 | 0.140 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.136 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.136 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.134 | |
| chemotaxis | GO:0006935 | 247 | 0.133 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.131 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.131 | |
| ear morphogenesis | GO:0042471 | 118 | 0.129 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.129 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.128 | |
| plasma membrane organization | GO:0007009 | 90 | 0.127 | |
| epithelial to mesenchymal transition | GO:0001837 | 47 | 0.127 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.127 | |
| fibrinolysis | GO:0042730 | 3 | 0.124 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.123 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.121 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.118 | |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.118 | |
| connective tissue replacement involved in inflammatory response wound healing | GO:0002248 | 3 | 0.117 | |
| epithelial cell development | GO:0002064 | 159 | 0.115 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.115 | Mouse |
| response to peptide hormone | GO:0043434 | 127 | 0.114 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.113 | |
| neuromuscular process | GO:0050905 | 99 | 0.111 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.111 | |
| lipid homeostasis | GO:0055088 | 63 | 0.111 | |
| digestive system development | GO:0055123 | 200 | 0.108 | |
| positive regulation of ras protein signal transduction | GO:0046579 | 13 | 0.107 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.106 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.106 | |
| endomembrane system organization | GO:0010256 | 147 | 0.105 | |
| protein maturation | GO:0051604 | 176 | 0.102 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.101 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.100 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.099 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.098 | |
| membrane organization | GO:0061024 | 245 | 0.098 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.097 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.096 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.096 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.096 | |
| respiratory system development | GO:0060541 | 190 | 0.096 | |
| lung alveolus development | GO:0048286 | 45 | 0.095 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.095 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.093 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.093 | |
| response to peptide | GO:1901652 | 136 | 0.092 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.091 | |
| prostate gland morphogenesis | GO:0060512 | 32 | 0.090 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.089 | |
| bone morphogenesis | GO:0060349 | 78 | 0.089 | |
| sensory perception of sound | GO:0007605 | 97 | 0.087 | |
| regulation of cell size | GO:0008361 | 72 | 0.087 | |
| mapk cascade | GO:0000165 | 281 | 0.085 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.085 | |
| negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001240 | 16 | 0.083 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.083 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.082 | |
| epithelial cell differentiation involved in mammary gland alveolus development | GO:0061030 | 4 | 0.082 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.081 | |
| trabecula formation | GO:0060343 | 24 | 0.081 | |
| positive regulation of cell growth | GO:0030307 | 33 | 0.079 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.079 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.078 | |
| bone trabecula formation | GO:0060346 | 9 | 0.078 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.078 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.078 | |
| circulatory system process | GO:0003013 | 197 | 0.078 | |
| regulation of axon extension | GO:0030516 | 43 | 0.077 | |
| negative regulation of cell substrate adhesion | GO:0010812 | 16 | 0.077 | |
| establishment of tissue polarity | GO:0007164 | 28 | 0.076 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.076 | |
| cell growth | GO:0016049 | 130 | 0.076 | |
| neuron projection guidance | GO:0097485 | 141 | 0.076 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.076 | |
| peripheral nervous system axon regeneration | GO:0014012 | 2 | 0.075 | |
| nephron epithelium development | GO:0072009 | 92 | 0.074 | |
| otic vesicle development | GO:0071599 | 14 | 0.074 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.072 | |
| mesenchymal epithelial cell signaling | GO:0060638 | 9 | 0.072 | |
| regulation of biomineral tissue development | GO:0070167 | 33 | 0.072 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.071 | |
| regulation of cell motility | GO:2000145 | 236 | 0.071 | |
| renal system development | GO:0072001 | 225 | 0.071 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.070 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.070 | |
| single organism nuclear import | GO:1902593 | 95 | 0.070 | |
| establishment of planar polarity | GO:0001736 | 28 | 0.069 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.069 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.068 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.068 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.067 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.067 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.067 | |
| substrate adhesion dependent cell spreading | GO:0034446 | 30 | 0.067 | |
| cell aggregation | GO:0098743 | 18 | 0.066 | |
| palate development | GO:0060021 | 76 | 0.066 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.066 | |
| response to alcohol | GO:0097305 | 48 | 0.066 | |
| otic vesicle morphogenesis | GO:0071600 | 10 | 0.066 | |
| regulation of sphingolipid biosynthetic process | GO:0090153 | 1 | 0.066 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.065 | |
| nuclear transport | GO:0051169 | 139 | 0.064 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.064 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.063 | |
| response to oxidative stress | GO:0006979 | 123 | 0.063 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.063 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.062 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.062 | |
| cellular response to vitamin | GO:0071295 | 2 | 0.062 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.062 | |
| collagen metabolic process | GO:0032963 | 17 | 0.061 | |
| developmental cell growth | GO:0048588 | 84 | 0.061 | |
| heart morphogenesis | GO:0003007 | 178 | 0.061 | |
| regulation of protein localization | GO:0032880 | 231 | 0.060 | |
| oviduct development | GO:0060066 | 3 | 0.060 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.060 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.060 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.059 | |
| establishment or maintenance of apical basal cell polarity | GO:0035088 | 21 | 0.059 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.058 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.058 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.058 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.058 | |
| striated muscle cell development | GO:0055002 | 125 | 0.058 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.058 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.057 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.057 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.056 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.056 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.056 | |
| regulation of system process | GO:0044057 | 200 | 0.056 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.056 | |
| chondroblast differentiation | GO:0060591 | 2 | 0.056 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.056 | |
| endoderm formation | GO:0001706 | 20 | 0.056 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.055 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.055 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.054 | |
| skin development | GO:0043588 | 220 | 0.054 | Mouse |
| negative regulation of cell development | GO:0010721 | 169 | 0.054 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.053 | |
| regulation of ossification | GO:0030278 | 112 | 0.052 | |
| response to bmp | GO:0071772 | 14 | 0.052 | |
| collagen biosynthetic process | GO:0032964 | 7 | 0.052 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.051 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.051 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.051 | |
| calcium ion transport | GO:0006816 | 159 | 0.051 | |
| synaptic transmission | GO:0007268 | 329 | 0.051 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.050 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.050 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.050 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 35 | 0.050 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.050 | |
| cellular response to retinoic acid | GO:0071300 | 25 | 0.049 | |
| cation transport | GO:0006812 | 399 | 0.049 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 26 | 0.049 | |
| biomineral tissue development | GO:0031214 | 64 | 0.049 | |
| glomerular basement membrane development | GO:0032836 | 8 | 0.049 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.049 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.049 | |
| extracellular fibril organization | GO:0043206 | 2 | 0.049 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.048 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.048 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.048 | |
| artery development | GO:0060840 | 53 | 0.048 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.048 | Zebrafish Mouse |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.048 | |
| neuron death | GO:0070997 | 154 | 0.047 | |
| cellular response to lipid | GO:0071396 | 145 | 0.047 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.047 | |
| intracellular protein transport | GO:0006886 | 204 | 0.047 | |
| intussusceptive angiogenesis | GO:0002041 | 2 | 0.047 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.047 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.046 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.046 | |
| gastrulation | GO:0007369 | 116 | 0.046 | |
| anion transport | GO:0006820 | 177 | 0.045 | |
| protein targeting | GO:0006605 | 143 | 0.045 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.045 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.045 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.045 | |
| membrane invagination | GO:0010324 | 17 | 0.045 | |
| positive regulation of peptide secretion | GO:0002793 | 33 | 0.045 | |
| learning or memory | GO:0007611 | 148 | 0.044 | |
| limb bud formation | GO:0060174 | 10 | 0.044 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.044 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.044 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.044 | |
| peripheral nervous system neuron axonogenesis | GO:0048936 | 3 | 0.044 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.043 | |
| response to radiation | GO:0009314 | 165 | 0.043 | |
| actin filament polymerization | GO:0030041 | 44 | 0.043 | |
| negative regulation of toll signaling pathway | GO:0045751 | 1 | 0.043 | |
| hormone metabolic process | GO:0042445 | 86 | 0.043 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.042 | |
| regulation of cell growth | GO:0001558 | 91 | 0.042 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.042 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.042 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.042 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.042 | |
| non canonical wnt signaling pathway | GO:0035567 | 33 | 0.041 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.041 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.041 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.041 | |
| collagen fibril organization | GO:0030199 | 32 | 0.041 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.040 | |
| cellular response to bmp stimulus | GO:0071773 | 14 | 0.040 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.040 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.040 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.040 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.040 | |
| regulation of ceramide biosynthetic process | GO:2000303 | 1 | 0.039 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.039 | |
| positive regulation of rho protein signal transduction | GO:0035025 | 7 | 0.039 | |
| oocyte axis specification | GO:0007309 | 2 | 0.039 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.039 | |
| fibril organization | GO:0097435 | 2 | 0.039 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.038 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.038 | |
| cognition | GO:0050890 | 149 | 0.038 | |
| neuronal action potential | GO:0019228 | 54 | 0.037 | |
| protein hydroxylation | GO:0018126 | 4 | 0.037 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.037 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.037 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.037 | |
| lipid localization | GO:0010876 | 126 | 0.036 | |
| protein trimerization | GO:0070206 | 13 | 0.036 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.036 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.036 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.036 | |
| blood coagulation | GO:0007596 | 76 | 0.036 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.036 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.036 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.036 | |
| response to metal ion | GO:0010038 | 47 | 0.035 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.035 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.035 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.035 | |
| protein catabolic process | GO:0030163 | 221 | 0.034 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.034 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.034 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.034 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.034 | |
| positive regulation of integrin mediated signaling pathway | GO:2001046 | 5 | 0.034 | |
| prostate gland epithelium morphogenesis | GO:0060740 | 31 | 0.034 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.033 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.033 | |
| regulation of phospholipid biosynthetic process | GO:0071071 | 3 | 0.033 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.033 | |
| peptide cross linking | GO:0018149 | 10 | 0.033 | |
| muscle fiber development | GO:0048747 | 76 | 0.033 | |
| heart contraction | GO:0060047 | 93 | 0.033 | |
| amine metabolic process | GO:0009308 | 45 | 0.033 | |
| cerebral cortex cell migration | GO:0021795 | 44 | 0.033 | |
| regulation of cell cycle g1 s phase transition | GO:1902806 | 35 | 0.033 | |
| positive regulation of cytoplasmic transport | GO:1903651 | 40 | 0.033 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.033 | |
| fat cell differentiation | GO:0045444 | 160 | 0.032 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.032 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.032 | |
| nephron development | GO:0072006 | 109 | 0.032 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.032 | |
| endocrine system development | GO:0035270 | 98 | 0.032 | |
| kidney epithelium development | GO:0072073 | 121 | 0.031 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.031 | |
| positive regulation of thymocyte migration | GO:2000412 | 2 | 0.031 | |
| regulation of epithelial cell migration | GO:0010632 | 35 | 0.031 | |
| response to steroid hormone | GO:0048545 | 56 | 0.031 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.031 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.030 | Mouse |
| female gonad development | GO:0008585 | 71 | 0.030 | Mouse |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.030 | |
| endothelial cell proliferation | GO:0001935 | 27 | 0.030 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.030 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.030 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.030 | |
| astrocyte differentiation | GO:0048708 | 43 | 0.030 | |
| protein folding | GO:0006457 | 28 | 0.030 | |
| stem cell differentiation | GO:0048863 | 268 | 0.030 | |
| camp metabolic process | GO:0046058 | 40 | 0.029 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.029 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.029 | |
| face morphogenesis | GO:0060325 | 29 | 0.029 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.029 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.029 | |
| protein localization to organelle | GO:0033365 | 185 | 0.029 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.029 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.029 | |
| negative regulation of neuron migration | GO:2001223 | 6 | 0.029 | |
| metanephric s shaped body morphogenesis | GO:0072284 | 2 | 0.029 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.029 | |
| developmental maturation | GO:0021700 | 193 | 0.029 | |
| axonogenesis | GO:0007409 | 274 | 0.029 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.029 | |
| membrane raft assembly | GO:0001765 | 3 | 0.028 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.028 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.028 | |
| positive regulation of receptor biosynthetic process | GO:0010870 | 1 | 0.028 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.028 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.028 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.028 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.028 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.028 | |
| positive regulation of growth | GO:0045927 | 104 | 0.028 | |
| protein localization to cell surface | GO:0034394 | 10 | 0.028 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.028 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.028 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.028 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.028 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.027 | |
| protein import into nucleus | GO:0006606 | 95 | 0.027 | |
| response to nutrient levels | GO:0031667 | 109 | 0.027 | |
| camera type eye development | GO:0043010 | 266 | 0.027 | |
| vegf activated neuropilin signaling pathway involved in axon guidance | GO:1902378 | 1 | 0.027 | |
| aorta morphogenesis | GO:0035909 | 22 | 0.027 | |
| response to fibroblast growth factor | GO:0071774 | 47 | 0.027 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.027 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.027 | |
| phagocytosis | GO:0006909 | 66 | 0.027 | |
| endothelial cell migration | GO:0043542 | 44 | 0.027 | |
| regulation of ion transport | GO:0043269 | 215 | 0.027 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.027 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.027 | |
| response to monosaccharide | GO:0034284 | 67 | 0.027 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.026 | |
| head morphogenesis | GO:0060323 | 34 | 0.026 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.026 | |
| axon ensheathment | GO:0008366 | 76 | 0.026 | |
| cell junction assembly | GO:0034329 | 52 | 0.026 | |
| positive regulation of endothelial cell migration | GO:0010595 | 12 | 0.026 | |
| negative regulation of osteoblast differentiation | GO:0045668 | 30 | 0.026 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.026 | |
| oocyte construction | GO:0007308 | 2 | 0.026 | |
| pancreas development | GO:0031016 | 57 | 0.026 | |
| female gamete generation | GO:0007292 | 74 | 0.025 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.025 | |
| protein localization to membrane | GO:0072657 | 108 | 0.025 | |
| negative regulation of tooth mineralization | GO:0070171 | 1 | 0.025 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.025 | |
| multicellular organismal metabolic process | GO:0044236 | 28 | 0.025 | |
| establishment of protein localization to membrane | GO:0090150 | 54 | 0.025 | |
| axon guidance | GO:0007411 | 141 | 0.025 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.025 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.025 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.025 | |
| locomotory exploration behavior | GO:0035641 | 10 | 0.025 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.024 | |
| response to catecholamine | GO:0071869 | 4 | 0.024 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.024 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.024 | |
| response to purine containing compound | GO:0014074 | 28 | 0.024 | |
| positive regulation of phospholipase activity | GO:0010518 | 3 | 0.024 | |
| positive regulation of camp metabolic process | GO:0030816 | 19 | 0.024 | |
| long chain fatty acid import | GO:0044539 | 2 | 0.024 | |
| negative regulation of neuron projection regeneration | GO:0070571 | 3 | 0.024 | |
| visual perception | GO:0007601 | 52 | 0.024 | |
| acetate ester transport | GO:1901374 | 2 | 0.023 | |
| lipid transport | GO:0006869 | 98 | 0.023 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.023 | Zebrafish Mouse |
| receptor biosynthetic process | GO:0032800 | 3 | 0.023 | |
| establishment of protein localization to plasma membrane | GO:0090002 | 34 | 0.023 | |
| regulation of translation | GO:0006417 | 71 | 0.023 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.023 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.023 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.023 | |
| glucose homeostasis | GO:0042593 | 128 | 0.023 | |
| sphingolipid biosynthetic process | GO:0030148 | 26 | 0.023 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.023 | |
| response to insulin | GO:0032868 | 100 | 0.023 | |
| response to epidermal growth factor | GO:0070849 | 4 | 0.022 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.022 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.022 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.022 | |
| tissue migration | GO:0090130 | 68 | 0.022 | |
| hemostasis | GO:0007599 | 78 | 0.022 | |
| response to retinoic acid | GO:0032526 | 56 | 0.022 | |
| lateral line system development | GO:0048925 | 1 | 0.022 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.022 | |
| glial cell development | GO:0021782 | 54 | 0.022 | |
| multicellular organism growth | GO:0035264 | 161 | 0.022 | |
| positive regulation of acute inflammatory response to non antigenic stimulus | GO:0002879 | 2 | 0.022 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.022 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.021 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.021 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.021 | |
| aldosterone metabolic process | GO:0032341 | 2 | 0.021 | |
| otolith morphogenesis | GO:0032474 | 3 | 0.021 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.021 | |
